Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 9, 2024 (Week 45)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 13,555 35,832 1,201,611 1,447,484
New England 639 1,128 39,703 47,289
Connecticut 103 296 7,479 11,555
Maine 53 81 2,297 2,585
Massachusetts 405 647 23,114 25,154
New Hampshire - 73 2,081 2,455
Rhode Island 78 389 3,680 4,388
Vermont - 33 1,052 1,152
Middle Atlantic 1,695 4,248 159,244 175,043
New Jersey 473 748 28,809 31,238
New York (excluding New York City) - 950 33,266 37,196
New York City 581 1,511 52,561 58,773
Pennsylvania 641 1,167 44,608 47,836
East North Central 1,601 4,573 150,916 198,414
Illinois 76 1,438 36,819 61,263
Indiana 393 698 27,040 29,891
Michigan 118 910 25,011 37,320
Ohio 663 1,153 42,472 48,104
Wisconsin 351 517 19,574 21,836
West North Central 771 1,987 75,618 85,423
Iowa 108 290 10,297 12,066
Kansas 138 288 10,083 11,806
Minnesota 94 486 16,966 18,998
Missouri 324 648 25,047 27,098
Nebraska - 208 6,958 8,100
North Dakota 39 87 2,649 3,021
South Dakota 68 108 3,618 4,334
South Atlantic 3,039 12,281 285,486 332,966
Delaware - 199 4,374 4,890
District of Columbia - 178 5,721 7,388
Florida 1,576 6,933 92,897 98,465
Georgia - 1,476 46,385 63,795
Maryland - 955 24,252 31,463
North Carolina 4 1,437 46,970 58,117
South Carolina 717 820 28,731 28,798
Virginia 740 911 32,667 36,215
West Virginia 2 112 3,489 3,835
East South Central 996 2,748 52,698 93,548
Alabama 604 889 27,367 29,395
Kentucky 295 592 14,052 14,736
Mississippi 97 1,006 11,279 17,210
Tennessee - 834 - 32,207
West South Central 870 4,646 170,234 197,163
Arkansas 167 399 13,693 15,771
Louisiana 354 750 29,023 31,971
Oklahoma 59 407 9,457 17,205
Texas 290 3,262 118,061 132,216
Mountain 1,187 2,691 90,195 101,310
Arizona 409 846 32,463 36,063
Colorado 406 857 20,800 22,112
Idaho 54 124 4,392 5,068
Montana 49 98 2,890 3,194
Nevada 20 344 12,546 13,761
New Mexico 67 229 7,494 9,809
Utah 182 239 8,689 9,682
Wyoming - 47 921 1,621
Pacific 2,757 4,838 177,517 216,328
Alaska 25 125 4,049 4,482
California 2,091 3,800 145,693 168,320
Hawaii - 145 - 5,528
Oregon 258 354 12,126 13,398
Washington 383 562 15,649 24,600
U.S. Territories - 121 667 4,599
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 121 667 4,599
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 3 4 43 46
Total 13,558 35,877 1,202,321 1,452,129
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.